Topical Beta Blockers in Small Infantile Hemangioma: State of the Art?
Journal Title: Journal of Regenerative Biology and Medicine - Year 2021, Vol 3, Issue 3
Abstract
Infantile hemangiomas (IH) are benign forms of endothelial proliferation in the first 8 weeks of life [1-11]. Leaute-Labreze et al. published the first spontaneous cases of IH treated with beta blockers in 2008 due to their cardiac disease in the New England Journal of Medicine. This was a revolutionary new understanding of treatment in infantile hemangioma (IH). Not only systemic but also topical beta blockers seem to be an effective treatment option for small infantile hemangioma. Efficacy and safety of topical beta blockers in the treatment of infantile hemangioma (IH) were proved in systematic reviews and meta-analysis [11].
Authors and Affiliations
Bittmann S*, Moschüring-Alieva E, Bittmann L, Luchter E, Villalon G
Stem Cell Therapies for Blindness due to Corneal, Lens, and Retinal Diseases: A Review
Stem cell therapies are continuing to be researched and implemented to treat a wide range of disorders that result in blindness. Major structures of the eye most prevalently tied to blindness are the cornea, lens, and re...
Joint Pressure, Volume and Alignment in Development of AOA: Indications for Orthobiologics and Surgeons
To fix and prevent, not ‘manage’ Osteoarthritis OA in the lower limb, should be the collective ‘Holy Grail’ with or without Orthobiologics OB. Lateral Ankle Sprain LAS, Chronic Ankle Instability CAI, and Ankle Osteoarthr...
L-PRF in Osteoarthritis Treatment: Results of a Pilot Study
Osteoarthritis (OA) is the most common chronic musculoskeletal disorder and is the most frequent single cause of disability in older adults [1]. OA is a chronic disease progressively involving the entire joint. Progressi...
Can IV Infusions of Bone Marrow Derived Mesenchymal Stem Cell Extracellular Vesicles be the Fountain of Youth?
There is increasing published literature to support the safety and efficacy of IV infusions of bone marrow-derived expanded allogeneic mesenchymal stem cells (MSCs) for the treatment of various auto-immune diseases. Frai...
Alice in Wonderland Syndrome: An Update of Present Data with a Special View to Body Position, Traumatic and Genetic Aspects
Alice in Wonderland Syndrome (AIWS) was named after the description of Lewis Carroll in his novel. In 1955, John Todd, a psychiatrist described this entity for the first time and results in a distortion of perception. To...